With confirmed COVID-19 cases worldwide surpassing 2.7 million and continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic and lessen the disease’s damage.
Some of the earliest treatments will likely be drugs that are already approved for other conditions, or have been tested on other viruses.
“People are looking into whether existing antivirals might work or whether new drugs could be developed to try to tackle the virus,” Dr. Bruce Y. Lee, a professor at the CUNY Graduate School of Public Health & Health Policy, said in March.
Antiviral drugs were a topic of a March 18 White House briefing on the COVID-19 outbreak.
President Trump said he was pushing the Food and Drug Administration (FDA) to eliminate barriers to get treatments to people with COVID-19.
With confirmed COVID-19 cases worldwide surpassing 2.7 million and continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic and lessen the disease’s damage.
Some of the earliest treatments will likely be drugs that are already approved for other conditions, or have been tested on other viruses.
“People are looking into whether existing antivirals might work or whether new drugs could be developed to try to tackle the virus,” Dr. Bruce Y. Lee, a professor at the CUNY Graduate School of Public Health & Health Policy, said in March.
SOURCE: healthline
